Inventor
DEPLAEN ETIENNE
BE9 patents
Patents
9 patentsUS5530096AJun 25, 1996
Isolated, tyrosinase derived peptides and uses thereof
LUDWIG INST CANCER RES22 citations92
US5763155AJun 9, 1998
Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3 gene products
LUDWIG INST CANCER RES16 citations78
US5512437AApr 30, 1996
Method for determining head and neck squamous cell carcinomas, prostate carcinomas, and bladder tumors by assaying for mage-3
LUDWIG INST CANCER RES11 citations71
US5763165AJun 9, 1998
Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3
LUDWIG INST CANCER RES14 citations70
US6265215B1Jul 24, 2001
Isolated peptides which complex with HLA-Cw16 and uses thereof
LUDWIG INST CANCER RES1 citations62
US5928938AJul 27, 1999
Isolated peptides which complex with HLA-Cw*16 molecules, and uses thereof
LUDWIG INST CANCER RES1 citations62
US5843688ADec 1, 1998
Isolated tyrosinase derived peptides and uses thereof
LUDWIG INST CANCER RES2 citations62
US6429287B1Aug 6, 2002
Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof
LUDWIG INST CANCER RES0 citations51
US6323028B1Nov 27, 2001
Isolated peptides which comply with HLA-CW16 molecules and uses
LUDWIG INST CANCER RES0 citations51